Definitions of Medicare Code Edits

Total Page:16

File Type:pdf, Size:1020Kb

Definitions of Medicare Code Edits Definitions of Medicare Code Edits DRAFT ICD-10 VERSION Software version 27.0 R1 PBL–031 September 2011 Manual updated March 2012 Document number PBL–031 September 2011 ii Definitions of Medicare Code Edits September 2011 About this document THE MEDICARE CODE EDITOR (MCE) detects and reports errors in the coding claims data. This manual contains a description of each coding edit with corresponding ICD-10-CM and ICD-10-PCS code lists which were published in December 2010. The coding edit information in this manual is effective from 10/01/2010 to 09/30/2011. However it is not intended to be used to process claims as the ICD- 10 code set will not be mandated for use until October 1, 2013. September 2011 iii iv Definitions of Medicare Code Edits September 2011 Contents Preface About this document iii Chapter 1 Edit code lists 1.3 1. Invalid diagnosis or procedure code 1.4 2. External causes of morbidity codes as principal diagnosis 1.4 3. Duplicate of PDX 1.4 4. Age conflict 1.4 5. Sex conflict 1.58 6. Manifestation code as principal diagnosis 1.161 7. Non-specific principal diagnosis 1.166 8. Questionable admission 1.166 9. Unacceptable principal diagnosis 1.167 10. Non-specific O.R. procedure 1.184 11. Non-covered procedure 1.184 12. Open biopsy check 1.191 13. Bilateral procedure 1.191 14. Invalid age 1.191 15. Invalid sex 1.191 16. Invalid discharge status 1.191 17. Limited coverage 1.192 18. Wrong procedure performed 1.193 Chapter 2 Code list changes 2.3 September 2011 Contents v vi Definitions of Medicare Code Edits September 2011 Chapter 1 1Edit code lists Contents Edit code lists 1.3 1. Invalid diagnosis or procedure code 1.4 2. External causes of morbidity codes as principal diagnosis 1.4 3. Duplicate of PDX 1.4 4. Age conflict 1.4 5. Sex conflict 1.58 6. Manifestation code as principal diagnosis 1.161 7. Non-specific principal diagnosis 1.166 8. Questionable admission 1.166 9. Unacceptable principal diagnosis 1.167 10. Non-specific O.R. procedure 1.184 11. Non-covered procedure 1.184 12. Open biopsy check 1.191 13. Bilateral procedure 1.191 14. Invalid age 1.191 15. Invalid sex 1.191 16. Invalid discharge status 1.191 17. Limited coverage 1.192 18. Wrong procedure performed 1.193 1.2 Definitions of Medicare Code Edits September 2011 Chapter 1 Edit code lists BELOW IS A LIST of edits described in this chapter. 1. Invalid diagnosis or procedure code 2. External causes of morbidity codes as principal diagnosis 3. Duplicate of PDX 4. Age conflict 5. Sex conflict 6. Manifestation code as principal diagnosis 7. Non-specific principal diagnosis (Discontinued as of 10/01/07) 8. Questionable admission 9. Unacceptable principal diagnosis 10. Non-specific O.R. procedure (Discontinued as of 10/01/07) 11. Non-covered procedure 12. Open biopsy check (Discontinued as of 10/01/10) 13. Bilateral procedure (Discontinued as of 10/01/13) 14. Invalid age 15. Invalid sex 16. Invalid discharge status 17. Limited coverage 18. Wrong procedure performed September 2011 Edit code lists 1.3 1. Invalid1. diagnosis Invalid or diagnosis procedure code or The Medicare Code Editor checks each diagnosis including the admit- procedure code ting diagnosis and each procedure against a table of valid ICD-10-CM and ICD-10-PCS codes. If an entered code does not agree with any code on the internal list, it is assumed to be invalid. For a list of all valid ICD-10-CM and ICD-10-PCS codes, see the International Classification of Diseases list. 2. External causes of morbidity codes as 2. Externalprincipal causes diagnosis of External causes of morbidity codes are ICD-10-CM codes beginning morbidity codes as principal with the letter V through Y. They describe the circumstance causing diagnosis an injury, not the nature of the injury, and therefore should not be used as a principal diagnosis. For a list of all external causes of morbidity codes, see the Interna- tional Classification of Diseases list. 3. Duplicate of PDX Whenever a secondary diagnosis is coded the same as the principal diagnosis, the secondary diagnosis is identified as a duplicate of the principal diagnosis. 4. Age conflict The Medicare Code Editor detects inconsistencies between a patient’s age and any diagnosis on the patient’s record. For example, a five-year-old patient with benign prostatic hypertrophy or a 78-year-old patient coded with a delivery. In the above cases, the diagnosis is clinically and virtually impossible in a patient of the stated age. Therefore, either the diagnosis or the age is presumed to be incorrect. There are four age categories for diagno- ses in the program: ◆ Newborn. Age of 0 years; a subset of diagnoses intended only for newborns and neonates (e.g., fetal distress, perinatal jaundice). ◆ Pediatric. Age range is 0–17 years inclusive (e.g., Reye’s syn- drome, routine child health exam). ◆ Maternity. Age range is 12–55 years inclusive (e.g., diabetes in pregnancy, antepartum pulmonary complication). ◆ Adult. Age range is 15–124 years inclusive (e.g., senile delirium, mature cataract). The following pages contain lists of ICD-10-CM diagnosis codes with corresponding English descriptions for each of the age categories described above. 1.4 Definitions of Medicare Code Edits September 2011 Newborn diagnoses A33 Tetanus neonatorum D807 Transient hypogammaglobulinemia of infancy E71511 Neonatal adrenoleukodystrophy E8411 Meconium ileus in cystic fibrosis H04531 Neonatal obstruction of right nasolacrimal duct H04532 Neonatal obstruction of left nasolacrimal duct H04533 Neonatal obstruction of bilateral nasolacrimal duct H04539 Neonatal obstruction of unspecified nasolacrimal duct N470 Adherent prepuce, newborn P000 Newborn affected by maternal hypertensive disorders P001 Newborn aff by maternal renal and urinary tract diseases P002 Newborn affected by maternal infec/parastc diseases P003 Newborn affected by oth maternal circ and resp diseases P004 Newborn affected by maternal nutritional disorders P005 Newborn (suspected to be) affected by maternal injury P006 Newborn affected by surgical procedure on mother P007 Newborn affected by oth medical procedures on mother, NEC P0081 Newborn affected by periodontal disease in mother P0089 Newborn affected by oth maternal conditions P009 Newborn affected by unsp maternal condition P010 Newborn (suspected to be) affected by incompetent cervix P011 Newborn (suspected to be) affected by premature ROM P012 Newborn (suspected to be) affected by oligohydramnios P013 Newborn (suspected to be) affected by polyhydramnios P014 Newborn (suspected to be) affected by ectopic pregnancy P015 Newborn (suspected to be) affected by multiple pregnancy P016 Newborn (suspected to be) affected by maternal death P017 Newborn affected by malpresentation before labor P018 Newborn affected by oth maternal complications of pregnancy P019 Newborn affected by maternal complication of pregnancy, unsp P020 Newborn (suspected to be) affected by placenta previa P021 Newborn affected by oth placental separation and hemorrhage P0220 Newborn aff by unsp morpholog and functn abnlt of placenta P0229 Newborn aff by oth morpholog and functn abnlt of placenta P023 Newborn affected by placental transfusion syndromes P024 Newborn (suspected to be) affected by prolapsed cord P025 Newborn affected by oth compression of umbilical cord P0260 Newborn affected by unsp conditions of umbilical cord P0269 Newborn affected by oth conditions of umbilical cord P027 Newborn (suspected to be) affected by chorioamnionitis P028 Newborn affected by oth abnormalities of membranes P029 Newborn affected by abnormality of membranes, unsp P030 Newborn affected by breech delivery and extraction P031 NB aff by oth malpresent, malpos & disproprtn dur labr & del P032 Newborn (suspected to be) affected by forceps delivery P033 Newborn affected by delivery by vacuum extractor P034 Newborn (suspected to be) affected by Cesarean delivery P035 Newborn (suspected to be) affected by precipitate delivery P036 Newborn affected by abnormal uterine contractions P03810 NB aff by abnlt in fetl heart rate or rhythm bef onset labor P03811 NB aff by abnlt in fetal heart rate or rhythm during labor P03819 NB aff by abnlt in fetl hrt rate or rhythm, unsp time onset P0382 Meconium passage during delivery P0389 Newborn affected by oth complications of labor and delivery P039 Newborn affected by complication of labor and delivery, unsp P040 NB aff by matern anesth and analgesia in preg, labor and del P041 Newborn affected by oth maternal medication P042 Newborn affected by maternal use of tobacco P043 Newborn affected by maternal use of alcohol P0441 Newborn affected by maternal use of cocaine P0449 Newborn affected by maternal use of drugs of addiction P045 Newborn aff by maternal use of nutritional chemical substnc P046 Newborn aff by maternal exposure to environ chemical substnc P048 Newborn affected by oth maternal noxious substances P049 Newborn affected by maternal noxious substance, unsp September 2011 Edit code lists 1.5 Newborn diagnoses P0500 Newborn light for gestational age, unspecified weight P0501 Newborn light for gestational age, less than 500 grams P0502 Newborn light for gestational age, 500-749 grams P0503 Newborn light for gestational age, 750-999 grams P0504 Newborn light for gestational age, 1000-1249 grams P0505 Newborn light for gestational age, 1250-1499 grams P0506 Newborn light for gestational age, 1500-1749 grams P0507 Newborn light for gestational age, 1750-1999 grams P0508 Newborn light for gestational age, 2000-2499 grams P0510 Newborn small for gestational age, unspecified weight P0511
Recommended publications
  • PT - 2020 Measure Value Set Avoidableed
    PT - 2020 Measure Value Set_AvoidableED Numerator Value Set Name Code Definition Code System N/A A09 Infectious gastroenteritis and colitis, unspecified ICD10CM N/A A630 Anogenital (venereal) warts ICD10CM N/A B069 Rubella without complication ICD10CM N/A B070 Plantar wart ICD10CM N/A B078 Other viral warts ICD10CM N/A B079 Viral wart, unspecified ICD10CM N/A B179 Acute viral hepatitis, unspecified ICD10CM N/A B199 Unspecified viral hepatitis without hepatic coma ICD10CM N/A B309 Viral conjunctivitis, unspecified ICD10CM N/A B354 Tinea corporis ICD10CM N/A B355 Tinea imbricata ICD10CM N/A B356 Tinea cruris ICD10CM N/A B483 Geotrichosis ICD10CM N/A B49 Unspecified mycosis ICD10CM N/A B80 Enterobiasis ICD10CM N/A B852 Pediculosis, unspecified ICD10CM N/A B853 Phthiriasis ICD10CM N/A B889 Infestation, unspecified ICD10CM N/A C61 Malignant neoplasm of prostate ICD10CM N/A E039 Hypothyroidism, unspecified ICD10CM N/A E215 Disorder of parathyroid gland, unspecified ICD10CM N/A E780 Pure hypercholesterolemia ICD10CM N/A E786 Lipoprotein deficiency ICD10CM N/A E849 Cystic fibrosis, unspecified ICD10CM N/A G5600 Carpal tunnel syndrome, unspecified upper limb ICD10CM N/A G5601 Carpal tunnel syndrome, right upper limb ICD10CM N/A G5602 Carpal tunnel syndrome, left upper limb ICD10CM N/A H00011 Hordeolum externum right upper eyelid ICD10CM N/A H00012 Hordeolum externum right lower eyelid ICD10CM N/A H00013 Hordeolum externum right eye, unspecified eyelid ICD10CM N/A H00014 Hordeolum externum left upper eyelid ICD10CM N/A H00015 Hordeolum externum
    [Show full text]
  • Hypocalcemia Associated with Subcutaneous Fat Necrosis of the Newborn: Case Report and Literature Review Alphonsus N
    case report Oman Medical Journal [2017], Vol. 32, No. 6: Hypocalcemia Associated with Subcutaneous Fat Necrosis of the Newborn: Case Report and Literature Review Alphonsus N. Onyiriuka 1* and Theodora E. Utomi2 1Endocrine and Metabolic Unit, Department of Child Health, University of Benin Teaching Hospital, Benin City, Nigeria 2Special Care Baby Unit, Department of Nursing Services, St Philomena Catholic Hospital, Benin City, Nigeria ARTICLE INFO ABSTRACT Article history: Subcutaneous fat necrosis of the newborn (SCFNN) is a rare benign inflammatory Received: 4 November 2015 disorder of the adipose tissue but may be complicated by hypercalcemia or less frequently, Accepted: 21 October 2016 hypocalcemia, resulting in morbidity and mortality. Here we report the case of a neonate Online: with subcutaneous fat necrosis who surprisingly developed hypocalcemia instead DOI 10.5001/omj.2017.99 of hypercalcemia. A full-term female neonate was delivered by emergency cesarean section for fetal distress and was subsequently admitted to the Special Care Baby Keywords: Hypocalcemia; Infant, Unit. The mother’s pregnancy was uncomplicated up to delivery. Her anthropometric Newborn; Subcutaneous Fat measurements were birth weight 4.1 kg (95th percentile), length 50 cm (50th percentile), Necrosis; Perinatal Stress. and head circumference 34.5 cm (50th percentile). The Apgar scores were 2, 3, and 8 at 1, 5, 10 minutes, respectively. There was no abnormal facies and she was fed with breast milk only. On the seventh day of life, the infant was found to have multiple nodules located in the neck, upper back, and right arm. The nodules were firm, well circumscribed with no evidence of tenderness.
    [Show full text]
  • ICD10 Diagnoses FY2018 AHD.Com
    ICD10 Diagnoses FY2018 AHD.com A020 Salmonella enteritis A5217 General paresis B372 Candidiasis of skin and nail A040 Enteropathogenic Escherichia coli A523 Neurosyphilis, unspecified B373 Candidiasis of vulva and vagina infection A528 Late syphilis, latent B3741 Candidal cystitis and urethritis A044 Other intestinal Escherichia coli A530 Latent syphilis, unspecified as early or B3749 Other urogenital candidiasis infections late B376 Candidal endocarditis A045 Campylobacter enteritis A539 Syphilis, unspecified B377 Candidal sepsis A046 Enteritis due to Yersinia enterocolitica A599 Trichomoniasis, unspecified B3781 Candidal esophagitis A047 Enterocolitis due to Clostridium difficile A6000 Herpesviral infection of urogenital B3789 Other sites of candidiasis A048 Other specified bacterial intestinal system, unspecified B379 Candidiasis, unspecified infections A6002 Herpesviral infection of other male B380 Acute pulmonary coccidioidomycosis A049 Bacterial intestinal infection, genital organs B381 Chronic pulmonary coccidioidomycosis unspecified A630 Anogenital (venereal) warts B382 Pulmonary coccidioidomycosis, A059 Bacterial foodborne intoxication, A6920 Lyme disease, unspecified unspecified unspecified A7740 Ehrlichiosis, unspecified B387 Disseminated coccidioidomycosis A080 Rotaviral enteritis A7749 Other ehrlichiosis B389 Coccidioidomycosis, unspecified A0811 Acute gastroenteropathy due to A879 Viral meningitis, unspecified B399 Histoplasmosis, unspecified Norwalk agent A938 Other specified arthropod-borne viral B440 Invasive pulmonary
    [Show full text]
  • Womens Health Requisition Forms
    PCR - WHI Implementation PLACE ON SWAB 10854 Midwest Industrial Blvd. St. Louis, MO 63132 MM DD YY Phone: (314) 200-3040 | Fax (314) 200-3042 (1) CLIA ID #26D0953866 JANE DOE v3 PCR MOLECULAR REQUISITION - WOMEN'S HEALTH INFECTION PRACTICE INFORMATION PATIENT INFORMATION *SPECIMEN INFORMATION (2) DOE JANE MM/DD/YY LAST NAME FIRST NAME DATE COLLECTED W O M E ' N S H E A L T H I F N E C T I O N SSN MM/DD/YY HH:MM AM SSN DATE OF BIRTH TIME COLLECTED REQUESTING PHYSICIAN: DR. SWAB TESTER (3) Sex: F X M (4) Diagnosis Codes X N76.0 Acute vaginitis B37.49 Other urogenital candidiasis A54.9 Gonococcal infection, unspecified N76.1 Subacute and chronic vaginitis N89.8 Other specified noninflammatory disorders of vagina A59.00 Urogenital trichomoniasis, unspecified N76.2 Acute vulvitis O99.820 Streptococcus B carrier state complicating pregnancy A64 Unspecified sexually transmitted disease N76.3 Subacute and chronic vulvitis O99.824 Streptococcus B carrier state complicating childbirth A74.9 Chlamydial infection, unspecified N76.4 Abscess of vulva B95.1 Streptococcus, group B, as the cause Z11.3 Screening for infections with a predmoninantly N76.5 Ulceration of vagina of diseases classified elsewhere sexual mode of trasmission N76.6 Ulceration of vulva Z22.330 Carrier of group B streptococcus Other: N76.81 Mucositis(ulcerative) of vagina and vulva N70.91 Salpingitis, unspecified N76.89 Other specified inflammation of vagina and vulva N70.92 Oophoritis, unspecified N95.2 Post menopausal atrophic vaginitis N71.9 Inflammatory disease of uterus, unspecified
    [Show full text]
  • Thyroid Disease in the Perinatal Period
    Thyroid Thyroid disease in Simon Forehan the perinatal period Background Thyroid dysfunction affects 2–3% of pregnant women and Thyroid hormone plays a critical role in fetal development. In one in 10 women of childbearing age with normal thyroid pregnancy, increased thyroid hormone synthesis is required to function have underlying thyroid autoimmunity, which may meet fetal needs, resulting in increased iodine requirements. indicate reduced functional reserve.1 Up to 18% of women in Objective the first trimester in Australia are thyroid antibody positive.2 This article outlines changes to thyroid physiology and Thyroid hormone plays a critical role in pregnancy and iodine requirements in pregnancy, pregnancy specific understanding the unique changes to thyroid physiology in reference ranges for thyroid function tests and detection and pregnancy has important implications for the definition and management of thyroid conditions in pregnancy. treatment of thyroid disorders in pregnancy. Discussion Thyroid dysfunction affects 2–3% of pregnant women. Pregnancy specific reference ranges are required to define Thyroid physiology and pregnancy thyroid conditions in pregnancy and to guide treatment. The fetus is dependent on transplacental transfer of maternal thyroxine Overt maternal hypothyroidism is associated with adverse (T4). Deiodination of maternal T4 by the fetus results in local fetal pregnancy outcomes; thyroxine treatment should be production of liothyronine (T3), which is particularly important for commenced immediately in this condition. Thyroxine neurological development.3,4 Maternal T3 does not cross the placenta treatment has also been shown to be effective for pregnant and appears to have little, if any, role in development. Other changes in women with subclinical hypothyroidism who are thyroid pregnancy include an increase in thyroid binding globulin (TBG), resulting peroxidase antibody positive.
    [Show full text]
  • N35.12 Postinfective Urethral Stricture, NEC, Female N35.811 Other
    N35.12 Postinfective urethral stricture, NEC, female N35.811 Other urethral stricture, male, meatal N35.812 Other urethral bulbous stricture, male N35.813 Other membranous urethral stricture, male N35.814 Other anterior urethral stricture, male, anterior N35.816 Other urethral stricture, male, overlapping sites N35.819 Other urethral stricture, male, unspecified site N35.82 Other urethral stricture, female N35.911 Unspecified urethral stricture, male, meatal N35.912 Unspecified bulbous urethral stricture, male N35.913 Unspecified membranous urethral stricture, male N35.914 Unspecified anterior urethral stricture, male N35.916 Unspecified urethral stricture, male, overlapping sites N35.919 Unspecified urethral stricture, male, unspecified site N35.92 Unspecified urethral stricture, female N36.0 Urethral fistula N36.1 Urethral diverticulum N36.2 Urethral caruncle N36.41 Hypermobility of urethra N36.42 Intrinsic sphincter deficiency (ISD) N36.43 Combined hypermobility of urethra and intrns sphincter defic N36.44 Muscular disorders of urethra N36.5 Urethral false passage N36.8 Other specified disorders of urethra N36.9 Urethral disorder, unspecified N37 Urethral disorders in diseases classified elsewhere N39.0 Urinary tract infection, site not specified N39.3 Stress incontinence (female) (male) N39.41 Urge incontinence N39.42 Incontinence without sensory awareness N39.43 Post-void dribbling N39.44 Nocturnal enuresis N39.45 Continuous leakage N39.46 Mixed incontinence N39.490 Overflow incontinence N39.491 Coital incontinence N39.492 Postural
    [Show full text]
  • Disseminated Eosinophilic Infiltration of a Newborn Infant, with Perforation of the Terminal Ileum and Bile Duct Obstruction
    Arch Dis Child: first published as 10.1136/adc.56.1.66 on 1 January 1981. Downloaded from 66 Shinozaki, Saito, and Shiraki infant who acquired hepatitis from her mother. Br Med J 6 Yoshida A, Tozawa M, Furukawa N, Oya N, Kusunoki T, 1970; iv: 719-21. Kiyosawa N. HBsAg-positive chronic active hepatitis in 3 Bancroft W H, Warkel R L, Talbert A A, Russell P K. a 1 and 1/2 year-old-child (in Japanese). Shonika Shinryo Family with hepatitis-associated antigen. JAMA 1971; 1977;40: 1246-50. 217:1817-20. McCarthy J W. Hepatitis B antigen (HBAg)-positive chronic aggressive hepatitis and cirrhosis in an 8-month- Correspondence to Dr T Shinozaki, Department of old infant. A case report. JPediatr 1973; 83: 638-9. Paediatrics, Teikyo University School of Medicine, 11-1 5 Fujiwara T, Abe M, Tachi N, Jo M, Shiroda M. Kaga, 2 Chome, Itabashi-ku, Tokyo 173, Japan. HBsAg-positive infantile hepatitis associated with chronic aggressive hepatitis (in Japanese). Shonika Rinsho 1975; 28:1303-6. Received 26 November 1979 Disseminated eosinophilic infiltration of a newborn infant, with perforation of the terminal ileum and bile duct obstruction S M MURRAY AND C J WOODS Department ofPathology and Department ofPaediatrics, Victoria Hospital, Blackpool Case report SUMMARY A preterm boy died 4 days after delivery from septicaemia which at necropsy was found to be A white boy, weighing 1490 g, was born by spon- due to perforation of an eosinophilic lesion of the taneous vertex delivery at 35 weeks' gestation to a copyright. terminal ileum.
    [Show full text]
  • Rwanda ICD-10 Diagnostic Code Subset
    Rwanda ICD-10 Diagnostic Code Subset ICD 10 code Diagnosis/Description A Infectious and parasitic diseases A00.0 CHOLERA DUE TO VIBRIO CHOLERAE 01_ BIOVAR CHOLERAE A01 TYPHOID AND PARATYPHOID FEVERS A01.0 TYPHOID FEVER A01.4 PARATYPHOID FEVER_ UNSPECIFIED A02 OTHER SALMONELLA INFECTIONS A02.0 SALMONELLA GASTROENTERITIS A02.1 SALMONELLA SEPTICEMIA A02.2 LOCALIZED SALMONELLA INFECTIONS A02.9 SALMONELLA INFECTION_ UNSPECIFIED A03 SHIGELLOSIS A03.0 SHIGELLOSIS DUE TO SHIGELLA DYSENTERIAE A03.2 SHIGELLOSIS DUE TO SHIGELLA BOYDII A03.9 SHIGELLOSIS_ UNSPECIFIED A04 OTHER BACTERIAL INTESTINAL INFECTIONS A04.0 ENTEROPATHOGENIC ESCHERICHIA COLI INFECTION A04.1 ENTEROTOXIGENIC ESCHERICHIA COLI INFECTION A04.4 OTHER INTESTINAL ESCHERICHIA COLI INFECTIONS A04.5 CAMPYLOBACTER ENTERITIS A04.7 ENTEROCOLITIS DUE TO CLOSTRIDIUM DIFFICILE A04.8 OTHER SPECIFIED BACTERIAL INTESTINAL INFECTIONS A04.9 BACTERIAL INTESTINAL INFECTION_ UNSPECIFIED A05 OTHER BACTERIAL FOOD-BORNE INTOXICATIONS A05.0 FOOD-BORNE STAPHYLOCOCCAL INTOXICATION A05.1 BOTULISM A05.4 FOOD-BORNE BACILLUS CEREUS INTOXICATION A05.8 OTHER SPECIFIED BACTERIAL FOOD-BORNE INTOXICATIONS A05.9 BACTERIAL FOOD-BORNE INTOXICATION_ UNSPECIFIED A06 AMEBIASIS A06.0 ACUTE AMEBIC DYSENTERY A06.1 CHRONIC INTESTINAL AMEBIASIS A06.2 AMEBIC NONDYSENTERIC COLITIS A06.3 AMEBOMA OF INTESTINE A06.4 AMEBIC LIVER ABSCESS A06.5 AMEBIC LUNG ABSCESS A06.6 AMEBIC BRAIN ABSCESS A06.7 CUTANEOUS AMEBIASIS A06.8 AMEBIC INFECTION OF OTHER SITES A06.9 AMEBIASIS_ UNSPECIFIED A07.0 BALANTIDIASIS A07.1 GIARDIASIS [LAMBLIASIS]
    [Show full text]
  • MFM Clinical Guideline
    MFM Clinical Guideline Thyroid Disease in Pregnancy Thyroid disease is the 2nd most common endocrinopathy in pregnancy after diabetes. In pregnancy: thyroid volume ↑ 30%, total/bound T3 and T4 levels ↑, but free/unbound T3 and T4 levels are stable due to ↑ thyroid binding globulin. In the 1st trimester, TSH levels ↓ due to high levels of hCG,which directly stimulates the TSH receptor, but return to baseline in the 2nd trimester. TSH does not cross the placenta. Maternal T4 is transferred to the fetus and is important for fetal brain development, especially before the fetal thyroid gland begins to synthesize thyroid hormone at 12-14 weeks. Screening for Thyroid Disease in Pregnancy Table 1: Screening. Table 2: Pregnancy reference ranges. Who to Screen Trimester TSH FT4* Age > 30 1st 0.1 - 2.5 0.8 - 1.2 BMI > 40 mIU/L ng/dL Current signs/symptoms of thyroid dysfunction 2nd 0.2 - 3 mIU/L 0.6 - 1 ng/dL Known positive thyroid antibodies 3rd 0.3 - 3 mIU/L 0.5 - 0.8 ng.dL Goiter *Due to inaccuracy of thyroid testing in pregnancy, Hx head/neck irradiation or thyroid surgery FT4 goal FHx thyroid disease should be the upper half of the reference range Pregestational diabetes Table 3: Interpreting the results. Autoimmune disorders TSH FT4 Hx of pregnancy loss, PTD, infertility Use of amiodarone or lithium, recent administration of Overt Hyperthyroidism ↓ ↑ iodinated radiologic contrast Subclinical ↓ NL Hyperthyroidism Residing in an area of known iodine deficiency Gestational 1st trim: ↓ UL How to Screen Hyperthyroidism 2nd trim: NL/ Step 1: TSH,
    [Show full text]
  • Diagnostic Tests for Vaginosis/Vaginitis
    Alberta Heritage Foundation for Medical Research Diagnostic tests for vaginosis/vaginitis Christa Harstall and Paula Corabian October 1998 HTA12 Diagnostic tests for vaginosis/vaginitis Christa Harstall and Paula Corabian October 1998 © Copyight Alberta Heritage Foundation for Medical Research, 1998 This Health Technology Assessment Report has been prepared on the basis of available information of which the Foundation is aware from public literature and expert opinion, and attempts to be current to the date of publication. The report has been externally reviewed. Additional information and comments relative to the Report are welcome, and should be sent to: Director, Health Technology Assessment Alberta Heritage Foundation for Medical Research 3125 Manulife Place, 10180 - 101 Street Edmonton Alberta T5J 3S4 CANADA Tel: 403-423-5727, Fax: 403-429-3509 This study is based, in part, on data provided by Alberta Health. The interpretation of the data in the report is that of the authors and does not necessarily represent the views of the Government of Alberta. ISBN 1-896956-15-7 Alberta's health technology assessment program has been established under the Health Research Collaboration Agreement between the Alberta Heritage Foundation for Medical Research and the Alberta Health Ministry. Acknowledgements The Alberta Heritage Foundation for Medical Research is most grateful to the following persons for their comments on the draft report and for provision of information. The views expressed in the final report are those of the Foundation. Dr. Jane Ballantine, Section of General Practice, Calgary Dr. Deirdre L. Church, Microbiology, Calgary Laboratory Services, Calgary Dr. Nestor N. Demianczuk, Royal Alexandra Hospital, Edmonton Dr.
    [Show full text]
  • Management of Endocrinopathies in Pregnancy: a Review of Current Evidence
    International Journal of Environmental Research and Public Health Review Management of Endocrinopathies in Pregnancy: A Review of Current Evidence Daniela Calina 1,† , Anca Oana Docea 2,*,†, Kirill Sergeyevich Golokhvast 3,†, Stavros Sifakis 4, Aristides Tsatsakis 5 and Antonis Makrigiannakis 6 1 Department of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania; [email protected] 2 Department of Toxicology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania 3 Scientific Education Center of Nanotechnology, Far Eastern Federal University, Vladivostok 690950, Russia; [email protected] 4 Department of Obstetrics and Gynecology, Mitera Maternity Hospital, 71110 Heraklion, Crete, Greece; [email protected] 5 Department of Forensic Sciences and Toxicology, Faculty of Medicine, University of Crete, 71110 Heraklion, Crete, Greece; [email protected] 6 Department of Obstetrics and Gynecology, Medical School, University of Crete, 71110 Heraklion, Crete, Greece; [email protected] * Correspondence: [email protected] † These authors contributed equally to this work. Received: 28 January 2019; Accepted: 27 February 2019; Published: 4 March 2019 Abstract: Pregnancy in women with associated endocrine conditions is a therapeutic challenge for clinicians. These disorders may be common, such us thyroid disorders and diabetes, or rare, including adrenal and parathyroid disease and pituitary dysfunction. With the development of assisted reproductive techniques, the number of pregnancies with these conditions has increased. It is necessary to recognize symptoms and correct diagnosis for a proper pharmacotherapeutic management in order to avoid adverse side effects both in mother and fetus. This review summarizes the pharmacotherapy of these clinical situations in order to reduce maternal and fetal morbidity.
    [Show full text]
  • Postpartum Thyroiditis
    FACT SHEET Postpartum Thyroiditis Inflammation can damage the thyroid, making it less able to WHAT IS POSTPARTUM produce thyroid hormone. This can lead to the second phase— THYROIDITIS? hypothyroidism. This phase may last up to a year. Too little thyroid hormone in your blood slows your metabolism. Many Postpartum thyroiditis is an inflammation of the thyroid gland. It women with hypothyroidism have a goiter—an enlarged thyroid usually occurs within a year after a woman gives birth. It affects gland that causes swelling in the front part of the neck. Other five to ten out of every 100 women after they deliver a baby. symptoms of hypothyroidism can include There are usually two phases of the disease—hyperthyroidism • Unexplained weight gain or inability to lose weight (too much thyroid hormone) and hypothyroidism (too little thyroid • Feeling tired or fatigued hormone). • Depression • Dry skin and brittle nails • Hair loss DID YOU KNOW? • Sensitivity to cold The thyroid gland, located in the front of your neck, releases a hormone that controls your metabolism—how your body uses and stores energy from food. In the usual first phase—hyperthyroidism—the inflamed thyroid gland leaks stored thyroid hormone (which consists of T3 and T4) into the blood. This phase usually lasts 2 to 4 months. Too much thyroid hormone in your blood causes your metabolism to speed up. Symptoms can include • Losing weight suddenly Thyroid • A fast heartbeat Gland • Tiredness • Feeling nervous • Sweating • Sensitivity to heat WHAT ARE THE RISKS OF POSTPARTUM THYROIDITIS? Questions to ask your doctor You are at greater risk of developing postpartum thyroiditis if you have an immune system disorder such as type 1 diabetes, a • Do my symptoms mean I might have personal or family history of thyroid disease, or had postpartum postpartum thyroiditis? thyroiditis before.
    [Show full text]